|
71 |
Disease reactivation after switching from natalizumab to daclizumab
Enthalten in Journal of neurology Bd. 264, 3.10.2017, Nr. 12, date:12.2017: 2491-2494
|
|
|
|
72 |
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
Enthalten in Nature Communications Bd. 9, 19.6.2018, Nr. 1, date:12.2018: 1-15
|
|
|
|
73 |
EGFL7 loss correlates with increased VEGF-D expression, upregulating hippocampal adult neurogenesis and improving spatial learning and memory
Enthalten in Cellular and molecular life sciences Bd. 80, 30.1.2023, Nr. 2, date:2.2023: 1-17
|
|
|
|
74 |
EGFL7 reduces CNS inflammation in mouse
Enthalten in Nature Communications Bd. 9, 26.2.2018, Nr. 1, date:12.2018: 1-12
|
|
|
|
75 |
Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension
Enthalten in Fluids and barriers of the CNS Bd. 20, 11.1.2023, Nr. 1, date:12.2023: 1-11
|
|
|
|
76 |
Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopy
Enthalten in Journal of neuroinflammation Bd. 17, 26.11.2020, Nr. 1, date:12.2020: 1-12
|
|
|
|
77 |
In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity
Enthalten in Journal of neuroinflammation Bd. 8, 6.10.2011, Nr. 1, date:12.2011: 1-12
|
|
|
|
78 |
Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose
Enthalten in DGNeurologie Bd. 4, 16.6.2021, Nr. 4, date:7.2021: 319-326
|
|
|
|
79 |
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis
Enthalten in Nature neuroscience Bd. 21, 26.9.2018, Nr. 10, date:10.2018: 1392-1403
|
|
|
|
80 |
Meilenstein oder verpasste Chance?
Enthalten in Der Nervenarzt Bd. 90, 7.2.2019, Nr. 2, date:2.2019: 183-184
|
|
Administration
